Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium

Clinical trial NCT02709031 · UNKNOWN

Trial details

NCT number: NCT02709031
Sponsor: Navitas Pharma
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Arterial Hypertension Diabetes Hypokalemia Hyponatremia

Start date: 2022-06-01
Primary completion: 2024-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.